Literature DB >> 18093156

Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease.

Carolyn M Hutter1, Ali Samii, Stewart A Factor, John G Nutt, Donald S Higgins, Thomas D Bird, Alida Griffith, John W Roberts, Berta C Leis, Jennifer S Montimurro, Denise M Kay, Karen L Edwards, Haydeh Payami, Cyrus P Zabetian.   

Abstract

UCHL1 has been proposed as a candidate gene for Parkinson's disease (PD). A meta-analysis of white and Asian subjects reported an inverse association between the non-synonymous UCHL1 S18Y polymorphism and PD risk. However, this finding was not replicated in a large case-control study and updated meta-analysis restricted to white subjects. We performed a case-control study of 1757 PD patients recruited from movement disorder clinics and 2016 unrelated controls from four regions of the United States. All subjects self-reported as white. We did not observe evidence for an association between S18Y genotypes and PD (overall P-value for association: P = 0.42). After adjustment for age, sex, and recruitment region, the odds ratio for Y/S versus S/S was 0.91 (95% CI: 0.78-1.06) and for Y/Y versus S/S was 0.87 (95% CI: 0.58-1.29). We also did not observe a significant association for recessive or dominant models of inheritance, or after stratification by age at onset, age at blood draw, sex, family history of PD, or recruitment region. Our results suggest that UCHL1 S18Y is not a major susceptibility factor for PD in white populations although we cannot exclude the possibility that the S18Y variant exerts weak effects on risk, particularly in early-onset disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18093156      PMCID: PMC2823263          DOI: 10.1111/j.1468-1331.2007.02012.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  26 in total

1.  The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease.

Authors:  G D Mellick; P A Silburn
Journal:  Neurosci Lett       Date:  2000-10-27       Impact factor: 3.046

2.  Genome scans and candidate gene approaches in the study of common diseases and variable drug responses.

Authors:  David B Goldstein; Kourosh R Ahmadi; Mike E Weale; Nicholas W Wood
Journal:  Trends Genet       Date:  2003-11       Impact factor: 11.639

Review 3.  Genetic causes of Parkinson's disease: UCHL-1.

Authors:  Daniel G Healy; Patrick M Abou-Sleiman; Nicholas W Wood
Journal:  Cell Tissue Res       Date:  2004-06-19       Impact factor: 5.249

4.  UCHL1 is associated with Parkinson's disease: a case-unaffected sibling and case-unrelated control study.

Authors:  Maurizio Facheris; Kari J Strain; Timothy G Lesnick; Mariza de Andrade; James H Bower; J Eric Ahlskog; Julie M Cunningham; Sarah Lincoln; Mathew J Farrer; Walter A Rocca; Demetrius M Maraganore
Journal:  Neurosci Lett       Date:  2005-02-25       Impact factor: 3.046

5.  The ubiquitin pathway in Parkinson's disease.

Authors:  E Leroy; R Boyer; G Auburger; B Leube; G Ulm; E Mezey; G Harta; M J Brownstein; S Jonnalagada; T Chernova; A Dehejia; C Lavedan; T Gasser; P J Steinbach; K D Wilkinson; M H Polymeropoulos
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

6.  Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease.

Authors:  D M Maraganore; M J Farrer; J A Hardy; S J Lincoln; S K McDonnell; W A Rocca
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

Review 7.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

Review 8.  Molecular pathophysiology of Parkinson's disease.

Authors:  Darren J Moore; Andrew B West; Valina L Dawson; Ted M Dawson
Journal:  Annu Rev Neurosci       Date:  2005       Impact factor: 12.449

9.  S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: evidence for an age-dependent relationship.

Authors:  Alexis Elbaz; Clotilde Levecque; Jacqueline Clavel; Jean-Sébastien Vidal; Florence Richard; Jean-René Corrèze; Bernard Delemotte; Philippe Amouyel; Annick Alpérovitch; Marie-Christine Chartier-Harlin; Christophe Tzourio
Journal:  Mov Disord       Date:  2003-02       Impact factor: 10.338

10.  S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden.

Authors:  Andrea Carmine Belin; Marie Westerlund; Olle Bergman; Hans Nissbrandt; Charlotta Lind; Olof Sydow; Dagmar Galter
Journal:  Parkinsonism Relat Disord       Date:  2007-02-06       Impact factor: 4.891

View more
  11 in total

1.  Exploring gene-environment interactions in Parkinson's disease.

Authors:  Colin C McCulloch; Denise M Kay; Stewart A Factor; Ali Samii; John G Nutt; Donald S Higgins; Alida Griffith; John W Roberts; Berta C Leis; Jennifer S Montimurro; Cyrus P Zabetian; Haydeh Payami
Journal:  Hum Genet       Date:  2008-01-22       Impact factor: 4.132

2.  Porcine UCHL1: genomic organization, chromosome localization and expression analysis.

Authors:  Knud Larsen; Lone Bruhn Madsen; Christian Bendixen
Journal:  Mol Biol Rep       Date:  2011-05-13       Impact factor: 2.316

Review 3.  Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson's disease: the impact of ethnicity and onset age.

Authors:  Ying Liu; Yan-Yan Chen; Hui Liu; Ci-Jiang Yao; Xiao-Xia Zhu; Dao-Jun Chen; Jin Yang; You-Jin Lu; Ji-Yu Cao
Journal:  Neurol Sci       Date:  2014-11-06       Impact factor: 3.307

4.  Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease.

Authors:  Madeleine Zetterberg; Annica Sjölander; Malin von Otter; Mona Seibt Palmér; Sara Landgren; Lennart Minthon; Anders Wallin; Niels Andreasen; Kaj Blennow; Henrik Zetterberg
Journal:  Mol Neurodegener       Date:  2010-03-19       Impact factor: 14.195

Review 5.  Mouse forward genetics in the study of the peripheral nervous system and human peripheral neuropathy.

Authors:  Darlene S Douglas; Brian Popko
Journal:  Neurochem Res       Date:  2008-05-15       Impact factor: 3.996

6.  Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy.

Authors:  Anna E Cartier; Kiren Ubhi; Brian Spencer; Ruben A Vazquez-Roque; Kori Ann Kosberg; Lawrence Fourgeaud; Priya Kanayson; Christina Patrick; Edward Rockenstein; Gentry N Patrick; Eliezer Masliah
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

7.  Ubiquitin carboxyl-terminal esterase L1 (UCHL1) S18Y polymorphism in patients with cataracts.

Authors:  Thiemo Rudolph; Annica Sjölander; Mona Seibt Palmér; Lennart Minthon; Anders Wallin; Niels Andreasen; Gunnar Tasa; Erkki Juronen; Kaj Blennow; Henrik Zetterberg; Madeleine Zetterberg
Journal:  Ophthalmic Genet       Date:  2011-01-26       Impact factor: 1.803

Review 8.  Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson's Disease: a HuGE review and meta-analysis.

Authors:  Margaret Ragland; Carolyn Hutter; Cyrus Zabetian; Karen Edwards
Journal:  Am J Epidemiol       Date:  2009-10-28       Impact factor: 4.897

9.  Genetic basis of Parkinson's disease: inheritance, penetrance, and expression.

Authors:  Claudia Schulte; Thomas Gasser
Journal:  Appl Clin Genet       Date:  2011-06-01

10.  UCHL1 S18Y variant is a risk factor for Parkinson's disease in Japan.

Authors:  Yoshihiro Miyake; Keiko Tanaka; Wakaba Fukushima; Chikako Kiyohara; Satoshi Sasaki; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Hiroyuki Shimada; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yoshio Hirota; Masaki Nagai
Journal:  BMC Neurol       Date:  2012-07-28       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.